We examined tumor sections by immunohistochemistry for Ki67 expression and found a marked decrease in Ki67-positive cells in TAM-treated tumors relative to control tumors suggesting that genomic deletion of Pfkfb3 decreases cell cycle progression in vivo (Figure 5E–H,N). Here, PFKFB3 is linked to neoplasm.